| scholarly article | Q13442814 |
| P50 | author | Petr Hermann | Q42836058 |
| Vojtěch Kubíček | Q57391736 | ||
| P2093 | author name string | Frank Rösch | |
| Jan Holub | |||
| Marian Meckel | |||
| P2860 | cites work | 1,4,7-Triazacyclononane-N,N',N''-triacetate (TCTA), a new hexadentate ligand for divalent and trivalent metal ions. Crystal structures of [CrIII(TCTA)], [FeIII(TCTA)], and Na[CuII(TCTA)].bul.2NaBr.bul.8H2O | Q57900847 |
| Structure and solution stability of indium and gallium complexes of 1,4,7-triazacyclononanetriacetate and of yttrium complexes of 1,4,7,10-tetraazacyclododecanetetraacetate and related ligands: kinetically stable complexes for use in imaging and radi | Q60171844 | ||
| Processing of generator-produced 68Ga for medical application. | Q64947317 | ||
| TRAP, a powerful and versatile framework for gallium-68 radiopharmaceuticals | Q82836384 | ||
| Stable aluminium fluoride chelates with triazacyclononane derivatives proved by X-ray crystallography and 18F-labeling study | Q84580573 | ||
| How is (68)Ga labeling of macrocyclic chelators influenced by metal ion contaminants in (68)Ge/(68)Ga generator eluates? | Q85390972 | ||
| Clinical applications of Gallium-68 | Q26849276 | ||
| Lanthanide(III) complexes of bis(phosphonate) monoamide analogues of DOTA: bone-seeking agents for imaging and therapy | Q31142241 | ||
| Gd(iii) complex of a monophosphinate-bis(phosphonate) DOTA analogue with a high relaxivity; Lanthanide(iii) complexes for imaging and radiotherapy of calcified tissues | Q33440687 | ||
| Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease | Q33870879 | ||
| Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium. | Q34119384 | ||
| (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives | Q34188331 | ||
| 'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents | Q36746390 | ||
| Synthesis and structural characterization of complexes of a DO3A-conjugated triphenylphosphonium cation with diagnostically important metal ions | Q36862058 | ||
| 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals | Q37126389 | ||
| The renaissance of the ⁶⁸Ge/⁶⁸Ga radionuclide generator initiates new developments in ⁶⁸Ga radiopharmaceutical chemistry | Q37768191 | ||
| Bone-seeking probes for optical and magnetic resonance imaging. | Q37855914 | ||
| Positron emitting [68Ga]Ga-based imaging agents: chemistry and diversity | Q37895281 | ||
| Bisphosphonates as radionuclide carriers for imaging or systemic therapy. | Q37924117 | ||
| A monoreactive bifunctional triazacyclononane phosphinate chelator with high selectivity for gallium-68. | Q39332186 | ||
| (68)Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter. | Q39341972 | ||
| Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging | Q39461465 | ||
| Gallium labeled NOTA-based conjugates for peptide receptor-mediated medical imaging | Q39627974 | ||
| Synthesis and evaluation of macrocyclic amino acid derivatives for tumor imaging by gallium-68 positron emission tomography | Q39647617 | ||
| Synthesis and Characterization of Nitroimidazole Derivatives for 68Ga-Labeling and Testing in Tumor Xenografted Mice | Q39670459 | ||
| THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience | Q42068740 | ||
| Bone-seeking TRAP conjugates: surprising observations and their implications on the development of gallium-68-labeled bisphosphonates. | Q42159954 | ||
| A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography. | Q42167262 | ||
| Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies. | Q42837828 | ||
| An osteoclast-targeting agent for imaging and therapy of bone metastasis | Q42945237 | ||
| In vivo comparison of DOTA based 68Ga-labelled bisphosphonates for bone imaging in non-tumour models. | Q44487212 | ||
| Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases | Q46121965 | ||
| Kinetics and thermodynamics of adsorption on hydroxyapatite of the [160Tb]terbium complexes of the bone-targeting ligands DOTP and BPPED. | Q46157913 | ||
| NODAPA-OH and NODAPA-(NCS)n: synthesis, 68Ga-radiolabelling and in vitro characterisation of novel versatile bifunctional chelators for molecular imaging | Q46332081 | ||
| Efficient synthesis and evaluation of bimodal ligand NETA. | Q46620038 | ||
| A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting | Q46817663 | ||
| PET/CT imaging of osteoblastic bone metastases with (68)Ga-bisphosphonates: first human study. | Q53315070 | ||
| Complexes of DOTA−Bisphosphonate Conjugates: Probes for Determination of Adsorption Capacity and Affinity Constants of Hydroxyapatite | Q57391344 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 122-134 | |
| P577 | publication date | 2014-05-06 | |
| P1433 | published in | Contrast Media & Molecular Imaging | Q2995750 |
| P1476 | title | Gallium(III) complexes of NOTA-bis (phosphonate) conjugates as PET radiotracers for bone imaging | |
| P478 | volume | 10 |
| Q38919414 | (177)Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment |
| Q55515922 | Bisphosphonate conjugation for bone specific drug targeting. |
| Q38729041 | Current advances in ligand design for inorganic positron emission tomography tracers (68)Ga, (64)Cu, (89)Zr and (44)Sc. |
| Q42630126 | Evaluation of Ga-DOTA-(D-Asp)n as bone imaging agents: D-aspartic acid peptides as carriers to bone. |
| Q53054964 | Evaluation of bone-seeking novel radiotracer 68Ga-NO2AP-Bisphosphonate for the detection of skeletal metastases in carcinoma breast. |
| Q92364315 | Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging |
| Q87980263 | Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators |
| Q38273277 | Radiometals: towards a new success story in nuclear imaging? |
| Q85637912 | The influence of the combination of carboxylate and phosphinate pendant arms in 1,4,7-triazacyclononane-based chelators on their 68Ga labelling properties |
| Q38709485 | [68Ga]/[188Re] Complexed [CDTMP] Trans-1,2-Cyclohexyldinitrilotetraphosphonic Acid As a Theranostic Agent for Skeletal Metastases |
Search more.